$200.00
Tesofensine Capsules 500mcg is an advanced, high-purity oral triple monoamine reuptake inhibitor engineered to study central satiety signaling, resting metabolic amplification, and neurocognitive pathways. By concurrently inhibiting the presynaptic reuptake of serotonin, norepinephrine, and dopamine, this precisely calibrated 500mcg capsule format serves as an elite investigative tool for tracking accelerated lipid oxidation, down-regulated food-seeking behaviors, and prefrontal neurotransmitter dynamics in laboratory models.
Supplied as stable, precisely standardized 500mcg research capsules. Restricted strictly to laboratory and in vitro evaluation.
Eterna Peptides presents premium-grade Tesofensine Capsules (500mcg), an advanced oral research formulation containing a high-purity monoamine reuptake inhibitor. Originally investigated for its neurodegenerative protective profiles, Tesofensine has emerged as an elite investigative compound within metabolic research and neurobiology. This precise 500mcg capsule format serves as a premier tool for tracking the synergistic modulation of central neurotransmitter pathways, signaling-driven appetite suppression, and elevated resting energy expenditure.
### Mechanism of Action
Tesofensine operates as a potent triple monoamine reuptake inhibitor (TRI), elegantly altering synaptic neurochemistry across three distinct monoamine neurotransmitter systems:
* **Noradrenergic & Serotonergic Reuptake Inhibition:** By blocking the presynaptic reuptake transporters for Norepinephrine and Serotonin, Tesofensine drives sustained synaptic concentrations of these key signaling molecules. In laboratory models, this action is closely monitored for its ability to induce powerful central satiety cascades, dulling baseline appetite pathways.
* **Dopaminergic Upregulation:** Tesofensine prevents the reuptake of Dopamine, reinforcing central reward-motivated behavior pathways. This component is actively investigated for its capacity to alter food-seeking motivation and modulate localized focus, drive, and cognitive longevity metrics.
* **Sympathetic Nervous System Activation:** Via central adrenergic pathways, Tesofensine triggers an upregulation of sympathetic outflow. This cascade is tracked for its direct impact on increasing resting metabolic rate, accelerating lipid oxidation ($ \beta\text{-oxidation} $), and inducing white adipose tissue energy expenditure.
* **Indirect Cholinergic Modulation:** Preclinical data suggests that Tesofensine increases extracellular acetylcholine levels in the prefrontal cortex, allowing researchers to evaluate its auxiliary roles in spatial memory consolidation and neurocognitive performance.
### Research Applications
In preclinical and in vitro laboratory models, Tesofensine Capsules 500mcg are actively utilized to investigate:
* High-velocity lipid mobilization, chronic obesity simulation, and resting metabolic rate adaptation.
* Central nervous system satiety signaling, arcuate nucleus neurotransmitter interaction, and behavioral food-reward attenuation.
* Prefrontal cortex neurotransmitter balancing, dopaminergic pathway resilience, and cognitive focus modeling.
* The comparative baseline bioavailability, peak concentration windows, and degradation curves of oral small-molecule reuptake inhibitors.
Our Tesofensine Capsules are precision-manufactured under strict laboratory quality control guidelines to ensure absolute ingredient standardization, high chemical purity, and dependable experimental reproducibility.
—
*Disclaimer: This product is sold strictly for laboratory research and development use only. It is not intended for human consumption, diagnostic, or therapeutic purposes.*
